Application of the LMPTP inhibitor in DIO mice increased liver insulin receptor (IRP) phosphorylation and reversed HFD-induced diabetes [31] which highlights its therapeutic potential against insulin resistance and diabetes. This evidence concerns the gene WNT2 and diabetes mellitus.